A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5–FU2 + irinotecan or LV5–FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer
2007 ◽
Vol 18
(12)
◽
pp. 2000-2005
◽
Y. Bécouarn
◽
P. Senesse
◽
S. Thézenas
◽
E. Boucher
◽
A. Adenis
◽
...
2007 ◽
Vol 73
(1-2)
◽
pp. 9-20
◽
Craig Underhill
◽
David Goldstein
◽
Vera A. Gorbounova
◽
Mikhail Y. Biakhov
◽
Igor S. Bazin
◽
...
2018 ◽
Vol 23
(8)
◽
pp. 919-927
◽
Goro Nakayama
◽
Ayako Mitsuma
◽
Yuki Sunagawa
◽
Kiyoshi Ishigure
◽
Hiroyuki Yokoyama
◽
...
2005 ◽
Vol 16
(2)
◽
pp. 282-288
◽
M.M. Borner
◽
J. Bernhard
◽
D. Dietrich
◽
R. Popescu
◽
M. Wernli
◽
...
Valerie Boige
◽
Jean Mendiboure
◽
Antoine Adenis
◽
Evelyne Boucher
◽
Jean-Yves Pierga
◽
...
2018 ◽
Vol 29
◽
pp. viii202
A. De Stefano
◽
G. Nasti
◽
A. Febbraro
◽
G. Rosati
◽
F. Giuliani
◽
...
2018 ◽
Vol 29
◽
pp. viii151
◽
S.B. Winther
◽
H. Skuladottir
◽
E. Hofsli
◽
C.-H. Shah
◽
M.K. Yilmaz
◽
...
2020 ◽
Vol 19
(2)
◽
pp. 109-115
Evaristo Maiello
◽
Gabriele Di Maggio
◽
Stefano Cordio
◽
Saverio Cinieri
◽
Francesco Giuliani
◽
...
2012 ◽
Vol 17
(7)
◽
pp. 937-946
◽
Herbert Hurwitz
◽
Edith P. Mitchell
◽
Thomas Cartwright
◽
Ambrose Kwok
◽
Sylvia Hu
◽
...
Close
Export Citation Format
Close
Share Document
Close